QuorumCivic. Hidden in plain sight Get the app
Bill intelligence
Full Simple

Congress legalizes delta-8 and HHC, raising hemp THC limit to 1%

S. 5736 — Hemp Guardrails Act · Filed by Tim Sheehy (R-MT) · 1 cosponsor · Introduced Nov 17, 2026 · Referred to committee

65%
Transparency
Typical bill: 85%
35/100
Hidden-provision risk
Typical bill: 15/100
High concernHemp Regulatory Legalization & Safety…

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill raises the legal threshold for hemp from 0.3% to 1.0% total THC (including THC-acid), and creates a new federal regulatory framework for hemp-derived cannabinoid products like delta-8, delta-10, and HHC. It establishes FDA oversight of these products through labeling, testing, manufacturing, and child-resistant packaging requirements, while explicitly excluding CBD and other non-intoxicating cannabinoids from restrictions. The bill allows unfinished cannabinoid ingredients to exceed 1% THC during processing if kept within the supply chain, and bans sales to anyone under 21.

Why we flagged it

The bill's core mechanism is a three-part shift: (1) raising the legal THC threshold to permit intoxicating cannabinoid products, (2) creating a new FDA regulatory chapter for hemp-derived cannabinoids, and (3) establishing safety standards. It is neither pure deregulation nor pure prohibition—it is legalization with federal oversight.

What the text implies

  • The 'restricted cannabinoids' definition (delta-8, delta-10, HHC, THC-O) is explicitly named, but the bill's language 'together with their isomers, analogs, esters, ethers, and salts' may not capture novel synthetic cannabinoids created after enactment, creating a moving-target regulatory problem.
  • Unfinished hemp-cannabinoid ingredients can exceed 1% THC during processing if kept within the supply chain—this creates a potential loophole if enforcement of 'exclusively with lawfully permitted actors' is weak, allowing high-THC intermediates to circulate.
  • The bill requires FDA to establish comprehensive manufacturing, testing, and labeling standards within 180 days—an aggressive timeline that may result in incomplete or overly permissive initial rules if FDA lacks resources.
  • State authority is preserved to enact stricter rules, but interstate commerce is protected—a state cannot block compliant products from entering. This creates a floor (federal minimum) but allows a patchwork of state ceilings, complicating compliance.
  • The bill does not address existing state hemp programs or the 2018 Farm Bill's regulatory framework; the interaction between federal and state hemp licensing is unclear.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Citizens gain access to a new category of legal intoxicating products with federal safety guardrails (testing, labeling, child-resistant packaging), but the bill also permits a largely unregulated market for delta-8/delta-10/HHC products that previously existed in a gray zone. The net effect depends on whether FDA enforcement is robust and whether the 1% threshold and 'restricted cannabinoid' definition effectively prevent circumvention through novel analogs.

Who stands to gain

  • hemp cultivators and processors (higher THC threshold permits larger crop value)
  • delta-8, delta-10, HHC manufacturers and retailers (legalization of previously gray-market products)
  • third-party testing laboratories (new testing requirements)
  • packaging and labeling suppliers (child-resistant packaging, QR code requirements)

Named in the bill

FDA (Food and Drug Administration), USDA (Department of Agriculture), hemp cultivators, cannabinoid product manufacturers, third-party testing laboratories, States and Indian Tribes, delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, hexahydrocannabinol (HHC), tetrahydrocannabinol acetate (THC-O-acetate), cannabidiol (CBD), Agricultural Marketing Act of 1946 — and 1 more

Where it stands

1 cosponsor: 1 Democrats.

  • Nov 17, 2026 — Introduced · Congress.gov: “Introduced in Senate”
  • Nov 17, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (14,650 characters) on Nov 21, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

As of — page rendered 2026-11-22.

“Congress legalizes delta-8 and HHC, raising hemp THC limit to 1%” QuorumCivic. https://share.quorumcivic.app/bill/119/s5736 Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.